Skip to main content
TipRanks
Go Ultimate75% OFF

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990) Financial Statements

2 Followers

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Financial Overview

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H's market cap is currently ¥105.17B. The company's EPS TTM is ¥0.55; its P/E ratio is 677.77; Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H is estimated to report earnings on March 29, 2027, and the estimated EPS forecast is ¥0.46. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 2.06B¥ 1.93B¥ 1.54B¥ 803.93M¥ 31.79M
Gross Profit¥ 1.48B¥ 1.27B¥ 759.18M¥ 527.11M¥ -10.93M
Operating Income¥ -466.19M¥ -211.40M¥ -452.61M¥ -393.93M¥ -798.79M
EBITDA¥ -249.23M¥ -47.36M¥ -308.31M¥ -351.19M¥ -775.80M
Net Income¥ -381.97M¥ -266.77M¥ -574.13M¥ -616.10M¥ -875.26M
Balance Sheet
Cash & Short-Term Investments¥ 4.56B¥ 3.08B¥ 2.53B¥ 117.54M¥ 100.31M
Total Assets¥ 5.99B¥ 4.27B¥ 3.51B¥ 993.14M¥ 996.97M
Total Debt¥ 88.44M¥ 126.75M¥ 59.92M¥ 3.01B¥ 2.93B
Net Debt¥ -3.24B¥ -1.22B¥ -1.51B¥ 2.90B¥ 2.83B
Total Liabilities¥ 1.12B¥ 959.34M¥ 1.18B¥ 4.22B¥ 4.24B
Stockholders' Equity¥ 4.87B¥ 3.31B¥ 2.33B¥ -3.21B¥ -3.24B
Cash Flow
Free Cash Flow¥ -306.55M¥ -510.89M¥ -22.69M¥ -309.84M¥ -609.73M
Operating Cash Flow¥ -180.30M¥ -429.77M¥ 59.56M¥ -270.85M¥ -517.18M
Investing Cash Flow¥ 411.01M¥ -822.00M¥ -1.03B¥ -32.15M¥ -92.84M
Financing Cash Flow¥ 1.73B¥ 1.04B¥ 2.38B¥ 313.45M¥ 675.92M

Currency in CNY

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Earnings and Revenue History

-1.2B01.2B2.4B-3000 %-2000 %-1000 %0 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Liabilities to Assets

02.5B5B7.5B0 %150 %300 %450 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Cash Flow

-2B-1B01B2B3B20212022202320242025OperatingInvestingFinancing

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Forecast EPS vs Actual EPS

-4-3-2-10123Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss